Nicotrol and Flexeril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nicotrol (nicotine) and Flexeril (cyclobenzaprine hydrochloride). Common drug interactions include withdrawal syndrome among females and ankle fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Nicotrol and Flexeril. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Nicotrol?

Nicotrol has active ingredients of nicotine. eHealthMe is studying from 4,104 Nicotrol users. Check the latest studies of Nicotrol.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.



On Jul, 24, 2026

46 people who take Nicotrol and Flexeril together, and have interactions are studied.

Nicotrol and Flexeril drug interactions.

What are the common drug interactions of Nicotrol and Flexeril, by gender? *:

female:

  1. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  2. Abnormal behaviour
  3. Acute myocardial infarction (acute heart attack)
  4. Application site bruising
  5. Application site dermatitis
  6. Application site erythema (redness of the skin at application site)
  7. Application site pruritus (application site severe itching of the skin)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Blood creatinine increased
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

male:

  1. Ankle fracture
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Fall
  4. Lung neoplasm malignant (cancer tumour of lung)
  5. Retching (strong involuntary effort to vomit)
  6. Rhinorrhoea (watery mucus discharge from the nose)
  7. Vertigo
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Arthralgia (joint pain)
  10. Disability

What are the common drug interactions of Nicotrol and Flexeril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug ineffective
  2. Suicidal ideation

40-49:

  1. Haematemesis (vomiting of blood)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Insomnia (sleeplessness)
  4. Labyrinthitis (inflammation of the labyrinth or inner ear)
  5. Oesophageal disorder (disease of oesophagus)
  6. Vision blurred
  7. Anxiety
  8. Arthralgia (joint pain)
  9. Drug ineffective
  10. Impaired work ability

50-59:

  1. Anxiety
  2. Blood cholesterol increased
  3. Depression
  4. Headache (pain in head)
  5. Hypertension (high blood pressure)
  6. Asthma
  7. Atherosclerosis (disorder of the arteries)
  8. Carotid artery stenosis (narrowing of carotid artery)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Disturbance in attention

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Tobacco withdrawal symptoms
  3. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  4. Application site bruising
  5. Application site dermatitis
  6. Application site erythema (redness of the skin at application site)
  7. Application site pruritus (application site severe itching of the skin)
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Fall
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

What are the existing conditions these people have? *

  1. Quit Smoking: 17 people, 36.96%
  2. Pain: 11 people, 23.91%
  3. Stress And Anxiety: 10 people, 21.74%
  4. Migraine (headache): 8 people, 17.39%
  5. Depression: 7 people, 15.22%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 13.04%
  7. Abdominal Discomfort: 5 people, 10.87%
  8. Neuralgia (pain in one or more nerves): 5 people, 10.87%
  9. Hypersensitivity: 5 people, 10.87%
  10. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 5 people, 10.87%

* Approximation only. Some reports may have incomplete information.

Do you take Nicotrol and Flexeril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nicotrol and Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nicotrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nicotrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nicotine and cyclobenzaprine hydrochloride (the active ingredients of Nicotrol and Flexeril, respectively), and Nicotrol and Flexeril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: